COVID-19 Project Team: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 15: | Line 15: | ||
**Mounika Vadiyala | **Mounika Vadiyala | ||
**Sara Haddadi | **Sara Haddadi | ||
<br> | |||
* Dermatologic Disorders of COVID-19 Team Members | * Dermatologic Disorders of COVID-19 Team Members | ||
<br> | |||
* Hematologic disorders and COVID-19 Team Members | * Hematologic disorders and COVID-19 Team Members | ||
<br> | |||
* Nephrologic Disorders and COVID-19 Team Members | * Nephrologic Disorders and COVID-19 Team Members | ||
**[[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]] | **[[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]] | ||
**Nasrin Nikravan | **Nasrin Nikravan | ||
<br> | |||
* Neurologic Disorders and COVID-19 Team Members | * Neurologic Disorders and COVID-19 Team Members | ||
**Muhammad Adnan Haider | **Muhammad Adnan Haider | ||
**[[User:Rinky Agnes Botleroo|Rinky Agnes Botleroo, M.D.]] | **[[User:Rinky Agnes Botleroo|Rinky Agnes Botleroo, M.D.]] | ||
**[[User:Harmeetkharoud91|Harmeet Kharoud]] | **[[User:Harmeetkharoud91|Harmeet Kharoud]] | ||
<br> | |||
* Ongoing Clinical Trials of COVID-19 Team Members | * Ongoing Clinical Trials of COVID-19 Team Members | ||
* Pulmonary Disorders and COVID-19 Team Members | * Pulmonary Disorders and COVID-19 Team Members | ||
**Rana Aljebzi | **Rana Aljebzi | ||
**[[User:Neepa Shah|Neepa Shah, M.B.B.S.]] | **[[User:Neepa Shah|Neepa Shah, M.B.B.S.]] | ||
<br> | |||
* Radiologic Manifestations of COVID-19 Team Members | * Radiologic Manifestations of COVID-19 Team Members | ||
<br> | |||
**[[User:Aisha Adigun|Aisha Adigun, M.D.]] | **[[User:Aisha Adigun|Aisha Adigun, M.D.]] | ||
**[[User:Bosky Soni|Bosky Soni, M.D., MPH]] | **[[User:Bosky Soni|Bosky Soni, M.D., MPH]] | ||
**Nuha Abdullah Alhowthi | **Nuha Abdullah Alhowthi | ||
**Oluwabusola Adogba | **Oluwabusola Adogba | ||
*[[User:Rija Gul|Rija Gul, M.D.]] | *[[User:Rija Gul|Rija Gul, M.D.]] | ||
*[[User:Roukoz Abou Karam|Roukoz Abou Karam, M.D.]] | *[[User:Roukoz Abou Karam|Roukoz Abou Karam, M.D.]] | ||
Revision as of 17:18, 10 June 2020
| COVID-19 Project |
|---|
| Introduction |
| Team |
| Meetings' Summary |
| Topics |
| Ongoing Clinical Trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Meet The Team
- Associate Editor(s)-in-Chief:
- Cardiovascular Disorders and COVID-19 Team Members
- Alieh Bahjat
- Mandana Chitsazan, M.D.
- Mandana Safakhah
- Mitra Chitsazan
- Mounika Vadiyala
- Sara Haddadi
- Dermatologic Disorders of COVID-19 Team Members
- Hematologic disorders and COVID-19 Team Members
- Nephrologic Disorders and COVID-19 Team Members
- Gurmandeep Singh Sandhu, M.B.B.S.
- Nasrin Nikravan
- Neurologic Disorders and COVID-19 Team Members
- Muhammad Adnan Haider
- Rinky Agnes Botleroo, M.D.
- Harmeet Kharoud
- Ongoing Clinical Trials of COVID-19 Team Members
- Pulmonary Disorders and COVID-19 Team Members
- Rana Aljebzi
- Neepa Shah, M.B.B.S.
- Radiologic Manifestations of COVID-19 Team Members
- Aisha Adigun, M.D.
- Bosky Soni, M.D., MPH
- Nuha Abdullah Alhowthi
- Oluwabusola Adogba
- Rija Gul, M.D.
- Roukoz Abou Karam, M.D.
- Huda A. Karman M.D., M.P.H., M.S.
- Sara Zand
- Sogand Goudarzi, M.D.
- Zaida Obeidat
- Vidhi Patel, M.B.B.S.
- Wajeeha Aiman
- Zaida Obeidat